Medicine prices increased up to 120 percent instead of DRAP approved 15 percent hike

Drug prices exorbitantly increased up to 120 % instead of DRAP approved 15 percent hike

Medicine prices have been increased many folds by the Pakistan pharmaceutical manufacturer association, and this increase, in some cases, is up to 120 %.

The increase in the prices has added to the problems of masses that are already facing an unprecedented price hike in the items of daily use.

The Drug Regulatory Authority of Pakistan (DRAP) has recently allowed the pharmaceutical industry to increase the prices of various brands of medicine up to 15 %. The DRPA has given this approval after the decision of the federal cabinet.

Sale of spurious and without warranty Drugs in Pakistan

The pharmaceutical industry had earlier demanded the increase in the prices of various medicine due to the devaluation of Pakistan currency and an increase in the dollar price. They believed that due to the increased in the prices of raw material at international level as a result of the devaluation of Pakistani rupee, a several-fold increase in the transportation and other manufacturing charges due to price hike of petroleum products, electricity and gas, the pharmaceutical manufacturer are unable to continue the production. They demanded of the govt that if prices of medicine are not increased the manufacturer will be left with no option but to stop the manufacturing units.

 

Keeping in view the logical demand of the pharmaceutical manufacturing the govt and DRAP agreed, in principle that an increase shall be granted to them to reduce the burden on the pharmaceutical industry. In this regard the DRAP, which is the sole representative body of the govt on pharmaceutical and medicine matters allowed the pharmaceutical industry to increase the prices of various brands of medicine from 9 to 15 %.

Drug Regulatory Authority is all set to start model Pharmacies at 4 different districts of KP

The pharmaceutical industries have taken advantage of this leniency and have increased the prices of medicine beyond the approval granted to them by the concerned authorities. In some case, this increased is more than 50 % of the total prices of the product.

Drug prices exorbitantly increased has been shown in the table

S.NO	Name of the Product	Old Price	New Price	% increase
1	Tab Proviran	257	586	128.01 %
2	Tab Triforge	186	510	174.19 %
3	Tab Avsar Plusv 160/10/25	176	405	130.00 %
4	Perfectil  Plus capsule	850	1800	111.76 %
5	Tab Concor 2.5 mg	60	125	108.33 %
6	Tab Erythromycin 250 mg	548	920	67.88 %
7	Tab Erythromycin 500 mg	1040	1500	44.23 %
8	Erythromycin syrup	66	97	46.97 %
9	Dettol Liquid	80	150	87.5 %
10	Tab Dupheston	540	828	53.33 %
11	Syrup Ginbex	440	695	57.95 %
12	Perfectil capsule	500	800	60.00 %
13	Tab Glyset 4mg	272	460	69.11 %
14	Injection IVF-C	920	1260	36.95 %
15	Tab Rifa 4 +	1215	2011	65.51 %
16	Tab Aldomet	638	840	31.66 %
17	Tab Primolut N	175	238	36.00 %
18	Epival	139	160	15.10 %
19	INSULIN	674	870	34.46 %
20	Cutis (Lotion)	270	540	100 %
21	Syrup Lysovit	62	90	45.16 %
22	Tab Zosartan – K	60	100	66.66 %
23	Calamox dry suspension	72	129	79.16 %
24	Tab Meliance	321	731	127.72 %
25	Tab Noctamid	246	525	113.41 %
26	Neurobion Tablets	250	750	200 %

It merits a mention here that at the time of approving to increase the prices of medicine, the DRAP had also directed the manufacturers to mention the old and new prices on the outer packing of medicinal products so that the people can do a comparison between the prices easily.

This direction of the DRAP has not been entertained by the manufacturers and not even a single product can be seen in the market having the old and new prices printed on its outer packing.

3 medicine are declared substandard by the Punjab Drug Testing Laboratory

The irony is that the higher authorities in the Drug Regulatory Authority of Pakistan have also shut their eyes towards such blatant violations by the pharmaceutical manufacturers. They seem reluctant to take any action against the strong lobby of pharmaceutical industries and the masses are left at the mercy of this cruel mafia.

The people demanded of the government to come hard on such violators of the law. The perpetrators and the culprit behind this gross negligence must be held accountable and such a constitutional right of the provision of basic health facility must not be snatched from the poor masses.

In October 2019, Pharmaceutical manufacturers have further increased the prices of various categories of medicine by 7. The per-table price of paracetamol has been increased up to 2 Rs. According to the official of the Ministry of Health, the DRAP ACT authorizes the Pharma industry to increase the prices up to 7 % per anum and the present increase is according to law.

There are up to 46 rupee increase in the prices of different category of medicine which are as follows

Weight control	Rs 31
Blood pressure medicine	Rs 12
Ulcer medicine	Rs 46
Sugar/diabetes medicine	Rs 30,
Pain killer	Rs 05